These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukemia: a randomised, heparin-controlled pilot study. Cofrancesco E; Boschetti C; Leonardi P; Gianese F; Cortellaro M Thromb Res; 1994 Apr; 74(1):65-75. PubMed ID: 8029809 [TBL] [Abstract][Full Text] [Related]
3. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. Martí-Carvajal AJ; Simancas D; Cardona AF Cochrane Database Syst Rev; 2011 Jun; (6):CD008562. PubMed ID: 21678379 [TBL] [Abstract][Full Text] [Related]
4. [Disseminated intravascular coagulation and primary fibrinolysis in acute leukemia]. Gafter U; Weiss S; Mandel M; Freudin N; Klein B; Djaldetti M Harefuah; 1977 Mar; 92(5):212-4. PubMed ID: 852758 [No Abstract] [Full Text] [Related]
5. [Hematologic diseases and disseminated intravascular coagulation]. Kobayashi N Rinsho Byori; 1985 Jun; Spec No 63():155-63. PubMed ID: 3900483 [No Abstract] [Full Text] [Related]
6. Effects of dermatan sulfate, a heparin cofactor II mediated thrombin inhibitor, on the endotoxin-induced disseminated intravascular coagulation model in the rat: comparison with low-molecular weight heparin, nafamostat mesilate and argathroban. Onaya J; Kyogashima M; Sunose A; Miyauchi S; Mizuno S; Horie K Jpn J Pharmacol; 1998 Apr; 76(4):397-404. PubMed ID: 9623718 [TBL] [Abstract][Full Text] [Related]